Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain Metastases

JAMA Netw Open. 2025 Apr 1;8(4):e254347. doi: 10.1001/jamanetworkopen.2025.4347.
No abstract available

Plain language summary

This cohort study evaluates whether immune-checkpoint inhibition therapy concurrent with radiosurgery is associated with risk of symptomatic radionecrosis among US patients with brain metastases.